INCREASED IMMUNOGENICITY AND PROTECTIVE EFFICACY IN OUTBRED AND INBRED MICE BY STRATEGIC CARBOXYL-TERMINAL TRUNCATION OF JAPANESE ENCEPHALITIS-VIRUS ENVELOPE GLYCOPROTEIN
Lr. Jan et al., INCREASED IMMUNOGENICITY AND PROTECTIVE EFFICACY IN OUTBRED AND INBRED MICE BY STRATEGIC CARBOXYL-TERMINAL TRUNCATION OF JAPANESE ENCEPHALITIS-VIRUS ENVELOPE GLYCOPROTEIN, The American journal of tropical medicine and hygiene, 48(3), 1993, pp. 412-423
We constructed recombinant vaccinia viruses expressing the full-length
envelope (E) glycoprotein of Japanese encephalitis virus (JEV) or a s
trategically truncated E glycoprotein, approximately 80% of the N-term
inal sequence, and compared their antigenic structure and protective i
mmunity in mice. The truncation site in the JEV E glycoprotein sequenc
e corresponds to the position that had been shown to increase the immu
nogenicity of dengue type 4 or type 2 virus E glycoprotein. Analysis o
f the JEV E glycoprotein in recombinant virus-infected cells showed th
at C-terminally truncated E retains an antigenic structure similar to
that of the full-length E glycoprotein. The full-length JEV E glycopro
tein was detected predominantly intracellularly, while a small fractio
n (< 2%) was present on the cell surface. On the other hand, the trunc
ated 80% E glycoprotein exhibited an alteration in the intracellular t
ransport pathway resulting in increased accumulation (10-25%) on the c
ell surface and secretion (6-10%) into the medium. The C-terminally tr
uncated E glycoprotein induced a greater antibody response and a highe
r level of protective immunity than did the full-length E glycoprotein
in outbred CD-1 mice as well as in two strains of inbred mice that di
ffer in their resistance to intraperitoneal (ip) JEV infection. In the
case of outbred CD-1 and inbred C57/B1 mice, which possess a dominant
autosomal genetic locus that controls resistance to a high dose of ip
infection of JEV or the capacity to acquire resistance to intracerebr
al JEV infection, truncated E glycoprotein induced a higher titer of J
EV neutralizing antibodies.